Galapagos: Pivoting From Clinical Risk To Strategic Capital Allocation
Source: SeekingAlpha
2025-12-22 05:39:33 ET
...
Read the full article on Seeking Alpha
For further details see:
Galapagos: Pivoting From Clinical Risk To Strategic Capital Allocation
Galapagos Genomics Ord
NASDAQ: GLPGF
GLPGF Trading
0.0% G/L:
$34 Last:
1,000 Volume:
$34 Open:
GLPGF Latest News
February 23, 2026 04:01:00 pm
Galapagos Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
GLPGF Stock Data
$2,214,141,586
49,160,084
N/A
238
N/A
Biotechnology & Life Sciences
Healthcare
BE
Mechelen
